A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://pubmed.ncbi.nlm.nih.gov/22939227/ below:

Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium

. 2012 Oct;205(10):479-87. doi: 10.1016/j.cancergen.2012.06.008. Epub 2012 Aug 29. Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium Phuong L Mai  1 David MalkinJudy E GarberJoshua D SchiffmanJeffrey N WeitzelLouise C StrongOliver WyssLuana LockeVon MeansMaria Isabel AchatzPierre HainautThierry FrebourgD Gareth EvansEveline BleikerAndrea PatenaudeKatherine SchneiderBenjamin WilfondJune A PetersPaul M HwangJames FordUri TaboriSimona OgnjanovicPhillip A DennisIngrid M WentzensenMark H GreeneJoseph F Fraumeni JrSharon A Savage

Affiliations

Affiliation

Item in Clipboard

Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium

Phuong L Mai et al. Cancer Genet. 2012 Oct.

. 2012 Oct;205(10):479-87. doi: 10.1016/j.cancergen.2012.06.008. Epub 2012 Aug 29. Authors Phuong L Mai  1 David MalkinJudy E GarberJoshua D SchiffmanJeffrey N WeitzelLouise C StrongOliver WyssLuana LockeVon MeansMaria Isabel AchatzPierre HainautThierry FrebourgD Gareth EvansEveline BleikerAndrea PatenaudeKatherine SchneiderBenjamin WilfondJune A PetersPaul M HwangJames FordUri TaboriSimona OgnjanovicPhillip A DennisIngrid M WentzensenMark H GreeneJoseph F Fraumeni JrSharon A Savage Affiliation

Item in Clipboard

Abstract

Li-Fraumeni syndrome (LFS) is a rare dominantly inherited cancer predisposition syndrome that was first described in 1969. In most families, it is caused by germline mutations in the TP53 gene and is characterized by early onset of multiple specific cancers and very high lifetime cumulative cancer risk. Despite significant progress in understanding the molecular biology of TP53, the optimal clinical management of this syndrome is poorly defined. We convened a workshop on November 2, 2010, at the National Institutes of Health in Bethesda, Maryland, bringing together clinicians and scientists, as well as individuals from families with LFS, to review the state of the science, address clinical management issues, stimulate collaborative research, and engage the LFS family community. This workshop also led to the creation of the Li-Fraumeni Exploration (LiFE) Research Consortium.

Published by Elsevier Inc.

PubMed Disclaimer

Similar articles Cited by References
    1. Palmero EI, Achatz MI, Ashton-Prolla P, et al. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome. Curr Opin Oncol. 2010;22:64–69. - PubMed
    1. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990;250:1233–1238. - PubMed
    1. Srivastava S, Zou ZQ, Pirollo K, et al. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 1990;348:747–749. - PubMed
    1. Li FP, Fraumeni JFJ. Soft-tissue sarcomas, breast cancer, and other neoplasms: A familial syndrome? Ann Intern Med. 1969;71:747–752. - PubMed
    1. Lustbader ED, Williams WR, Bondy ML, et al. Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients. Am J Hum Genet. 1992;51:344–356. - PMC - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3